CoChat

Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities

Open access
Irwin, Mary E., Rivera-Del Valle, Nilsa, Chandra, Joya · 2013 · Antioxidants & Redox Signaling
Cited by 136

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Reactive oxygen species (ROS) play both positive and negative roles in the proliferation and survival of a cell. This dual nature has been exploited by leukemia cells to promote growth, survival, and genomic instability—some of the hallmarks of the cancer phenotype. In addition to altered ROS levels, many antioxidants are dysregulated in leukemia cells. Together, the production of ROS and the expression and activity of antioxidant enzymes make up the primary redox control of leukemia cells. By manipulating this system, leukemia cells gain proliferative and survival advantages, even in the face of therapeutic insults. Standard treatment options have improved leukemia patient survival rates in recent years, although relapse and the development of resistance are persistent challenges. Therapies targeting the redox environment show promise for these cases. This review highlights the molecular mechanisms that control the redox milieu of leukemia cells. In particular, ROS production by the mitochondrial electron transport chain, NADPH oxidase, xanthine oxidoreductase, and cytochrome P450 will be addressed. Expression and activation of antioxidant enzymes such as superoxide dismutase, catalase, heme oxygenase, glutathione, thioredoxin, and peroxiredoxin are perturbed in leukemia cells, and the functional consequences of these molecular alterations will be described. Lastly, we delve into how these pathways can be potentially exploited therapeutically to improve treatment regimens and promote better outcomes for leukemia patients. Antioxid. Redox Signal. 18, 1349–1383. I. Introduction II. How Does ROS Affect Leukemia? A. Background on leukemia B. Leukemic oncogenes C. How do leukemic oncogenes control the redox environment? III. Mechanisms of ROS Production in Leukemia A. Mitochondrial respiration: a source of life and death for the leukemia cell B. NOX as a source of oncogene-induced ROS C. Metabolic/detoxification pathways and ROS production in leukemia IV. Cellular Antioxidants in Leukemia A. Nrf2: a master regulator of antioxidant transcription B. Enzymatic elimination of ROS 1. Superoxide dismutase 2. Catalase 3. Heme oxygenase 4. Glutathione 5. Thioredoxin 6. Peroxiredoxin V. ROS-Dependent Therapeutic Agents A. Standard-of-care chemotherapeutic agents and modulation of oxidative stress 1. Purine analogs: cytarabine and fludarabine 2. Mitotic inhibitor: vincristine 3. Anthracyclines B. Recently approved ROS-producing agents 1. Arsenic trioxide 2. Histone deacetylase inhibitors 3. Proteasome inhibitors C. Preclinical redox modifying compounds for the treatment of leukemia 1. Preclinical ROS inhibition a. NOX inhibitors b. Xanthine oxidoreductase inhibitors c. SOD and catalase delivery 2. Preclinical ROS induction a. HO-1 inhibitors (protoporphyrins) b. Trx pathway inhibitors c. Isothiocyanates d. Adaphostin e. Piperlongumine f. Parthenolide VI. Summary/Remarks

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/ars.2011.4258

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

Metadata

Authors
Irwin, M. E., Rivera-Del Valle, N., & Chandra, J.
Venue
Antioxidants & Redox Signaling
Published
2013-04-10
Volume
18
Issue
11
Pages
1349-1383
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
OpenAlex
W2008085394
Cited by
136
References
21
FWCI
3.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.